Data as of Jul 31
| -0.21 / -5.37%|
The 1 analysts offering 12-month price forecasts for Oxygen Biotherapeutics Inc have a median target of 10.50, with a high estimate of 10.50 and a low estimate of 10.50. The median estimate represents a +183.78% increase from the last price of 3.70.
The current consensus among 1 polled investment analysts is to Buy stock in Oxygen Biotherapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.